Malfettone A - Search Results

1

High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.

Malfettone A, Silvestris N, Saponaro C, Ranieri G, Russo A, Caruso S, Popescu O, Simone G, Paradiso A, Mangia A. Malfettone A, et al. J Cell Mol Med. 2013 Aug;17(8):1025-37. doi: 10.1111/jcmm.12073. J Cell Mol Med. 2013. PMID: 23991686 Free PMC article.

2

Nuclear NHERF1 expression as a prognostic marker in breast cancer.

Paradiso A, Scarpi E, Malfettone A, Addati T, Giotta F, Simone G, Amadori D, Mangia A. Paradiso A, et al. Among authors: malfettone a. Cell Death Dis. 2013 Nov 7;4(11):e904. doi: 10.1038/cddis.2013.439. Cell Death Dis. 2013. PMID: 24201803 Free PMC article.

3

Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers.

Mangia A, Malfettone A, Saponaro C, Tommasi S, Simone G, Paradiso A. Mangia A, et al. Among authors: malfettone a. Hum Pathol. 2011 Nov;42(11):1589-95. doi: 10.1016/j.humpath.2011.01.010. Epub 2011 Apr 14. Hum Pathol. 2011. PMID: 21496870

4

Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour.

Bellizzi A, Mangia A, Malfettone A, Cardone RA, Simone G, Reshkin SJ, Paradiso A. Bellizzi A, et al. Among authors: malfettone a. Histopathology. 2011 Jun;58(7):1086-95. doi: 10.1111/j.1365-2559.2011.03844.x. Histopathology. 2011. PMID: 21707710

5

Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation.

Mangia A, Malfettone A, Rossi R, Paradiso A, Ranieri G, Simone G, Resta L. Mangia A, et al. Among authors: malfettone a. Histopathology. 2011 Jun;58(7):1096-106. doi: 10.1111/j.1365-2559.2011.03842.x. Histopathology. 2011. PMID: 21707711

6

Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.

Malfettone A, Saponaro C, Paradiso A, Simone G, Mangia A. Malfettone A, et al. BMC Cancer. 2012 Mar 22;12:106. doi: 10.1186/1471-2407-12-106. BMC Cancer. 2012. PMID: 22439624 Free PMC article.

7

Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype.

Malfettone A, Silvestris N, Paradiso A, Mattioli E, Simone G, Mangia A. Malfettone A, et al. Exp Mol Pathol. 2012 Jun;92(3):296-303. doi: 10.1016/j.yexmp.2012.03.004. Epub 2012 Mar 13. Exp Mol Pathol. 2012. PMID: 22440733

8

Involvement of nuclear NHERF1 in colorectal cancer progression.

Mangia A, Saponaro C, Malfettone A, Bisceglie D, Bellizzi A, Asselti M, Popescu O, Reshkin SJ, Paradiso A, Simone G. Mangia A, et al. Among authors: malfettone a. Oncol Rep. 2012 Sep;28(3):889-94. doi: 10.3892/or.2012.1895. Epub 2012 Jul 3. Oncol Rep. 2012. PMID: 22766563

9

The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.

Saponaro C, Malfettone A, Dell'Endice TS, Brunetti AE, Achimas-Cadariu P, Paradiso A, Mangia A. Saponaro C, et al. Among authors: malfettone a. Cancer Biomark. 2014;14(2-3):177-84. doi: 10.3233/CBM-130329. Cancer Biomark. 2014. PMID: 24878819 Review.

10

RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease.

Bellizzi A, Mangia A, Chiriatti A, Petroni S, Quaranta M, Schittulli F, Malfettone A, Cardone RA, Paradiso A, Reshkin SJ. Bellizzi A, et al. Among authors: malfettone a. Int J Mol Med. 2008 Jul;22(1):25-31. Int J Mol Med. 2008. PMID: 18575772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters